News
Life Biosciences delivers first partial reprogramming gene therapy to glaucoma patients
2+ hour, 34+ min ago (551+ words) Experimental treatment aims to regenerate damaged optic nerves and restore aged cell function in up to 12 patients A gene therapy designed to revert aged cells to a more youthful state has been administered to humans for the first time. This…...
Scientists manage to correct genes in human embryos before birth with unprecedented precision, and the discovery reignites the debate on hereditary diseases, the future of babies, and the limits of genetics.
7+ hour, 57+ min ago (227+ words) China manufactured so many solar panels that the world cannot absorb them, and now sees its own industry collapsing: 1, 000 GW of capacity, more than 40 companies bankrupt, and modules sold below cost expose the paradox of cheap clean energy. The giant…...
Kolon Life Science Secures Canadian Patent Registration for KLS-3021 Manufacturing Technology
7+ hour, 36+ min ago (271+ words) Published 10 Jun. 2026 09: 08(KST) Kolon Life Science announced on June 10 that it has received a decision for the registration of its manufacturing technology patent for the anticancer gene therapy candidate KLS-3021 in Canada. This follows the initial registration of the patent…...
Bridging the Gap: The LNP Alliance on Translating Nucleic Acid Therapeutics from Lab to Clinic
11+ hour, 58+ min ago (666+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
Schematic overview of the IVSA platform for in vivo self-assembly and targeted delivery of EGFR si RNA.
14+ hour, 5+ min ago (55+ words) Eurek Alert! Schematic overview of the IVSA platform for in vivo self-assembly and targeted delivery of EGFR si RNA. More on this News Release Nanjing University team develops a novel targeted therapy for EGFR-driven tumors using IVSA technology...
SANA: Gene-modified islet and in vivo CAR T therapies advance toward pivotal trials and key data in 2024 " Trading View News
10+ hour, 30+ min ago (90+ words) SANA: Gene-modified islet and in vivo CAR T therapies advance toward pivotal trials and key data in 2024 Trading View The company is advancing two major platforms: a gene-modified islet therapy for type 1 diabetes aiming for a functional cure, and an…...
Columbia researchers use base editing to modify human embryo genome
15+ hour, 45+ min ago (22+ words) Bio World News Columbia researchers use base editing to modify human embryo genome...
Base editing in human embryos fixes some mutations and creates others
11+ hour, 17+ min ago (400+ words) The work proves that embryo editing is far from a clinical reality. But the experiment has sparked controversy nonetheless On June 1, an international group of industry and academic collaborators, led by geneticist Dieter Egli at Columbia University, released a preprint…...
Fifteenth In Vivo Lentiviral Vector-Based Therapeutic Technology Added to VIVEbiotech's CGT Platform
7+ hour, 37+ min ago (396+ words) Growing interest in in vivo cell and gene therapies is driving significant investment, given their potential to address some of the manufacturing and commercialization challenges associated with current ex vivo approaches. The post Fifteenth In Vivo Lentiviral Vector-Based Therapeutic Technology…...
Efficient Prime Editors Enable Multiplex Genome Editing in Soybean
15+ hour, 18+ min ago (726+ words) Bioengineer. org Efficient Prime Editors Enable Multiplex Genome Editing in Soybean In a groundbreaking advancement for plant biotechnology, researchers have unveiled a newly optimized prime editing system tailored specifically for soybean, overcoming longstanding efficiency barriers in dicotyledonous plants. This pioneering…...